135 related articles for article (PubMed ID: 10197625)
1. A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression.
Ogawa M; Umehara K; Yu WG; Uekusa Y; Nakajima C; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1999 Apr; 59(7):1531-8. PubMed ID: 10197625
[TBL] [Abstract][Full Text] [Related]
2. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
3. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
[TBL] [Abstract][Full Text] [Related]
4. The development of peritumoral stroma required for IL-12 induced tumor regression depends on the T cell/IFN-gamma-involving host-tumor interaction.
Uekusa Y; Ogawa M; Gao P; Iwasaki M; Ono S; Tsujimura T; Nakazawa M; Sakuda M; Clancy B; Fujiwara H; Hamaoka T
Int J Oncol; 2000 Apr; 16(4):805-14. PubMed ID: 10717251
[TBL] [Abstract][Full Text] [Related]
5. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12.
Ogawa M; Tsutsui T; Zou JP; Mu J; Wijesuriya R; Yu WG; Herrmann S; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1997 Jun; 57(11):2216-22. PubMed ID: 9187124
[TBL] [Abstract][Full Text] [Related]
6. Administration of IL-12 induces a CD3+ CD4- CD8- B220+ lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells.
Tsutsui T; Mu J; Ogawa M; Yu WG; Suda T; Nagaga S; Saji F; Murata Y; Fujiwara H; Hamaoka T
J Immunol; 1997 Sep; 159(6):2599-605. PubMed ID: 9300678
[TBL] [Abstract][Full Text] [Related]
7. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.
Zou JP; Shimizu J; Ikegame K; Yamamoto N; Ono S; Fujiwara H; Hamaoka T
J Immunol; 1992 Jan; 148(2):648-55. PubMed ID: 1345922
[TBL] [Abstract][Full Text] [Related]
8. A role for endogenous IL-12 in tumor immunity: IL-12 is required for the acquisition of tumor-migratory capacity by T cells and the development of T cell-accepting capacity in tumor masses.
Uekusa Y; Gao P; Yamaguchi N; Tomura M; Mukai T; Nakajima C; Iwasaki M; Takeuchi N; Tsujimura T; Nakazawa M; Fujiwara H; Hamaoka T
J Leukoc Biol; 2002 Nov; 72(5):864-73. PubMed ID: 12429708
[TBL] [Abstract][Full Text] [Related]
9. MaMi, a human endometrial stromal sarcoma cell line that constitutively produces interleukin-6, interleukin-8, and monocyte chemoattractant protein-1.
Nasu K; Matsui N; Narahara H; Tanaka Y; Takai N; Miyakawa I; Higuchi Y
Arch Pathol Lab Med; 1998 Sep; 122(9):836-41. PubMed ID: 9740146
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.
Yu WG; Yamamoto N; Takenaka H; Mu J; Tai XG; Zou JP; Ogawa M; Tsutsui T; Wijesuriya R; Yoshida R; Herrmann S; Fujiwara H; Hamaoka T
Int Immunol; 1996 Jun; 8(6):855-65. PubMed ID: 8671675
[TBL] [Abstract][Full Text] [Related]
11. Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive versus -unresponsive tumor models.
Iwasaki M; Yu WG; Uekusa Y; Nakajima C; Yang YF; Gao P; Wijesuriya R; Fujiwara H; Hamaoka T
Int Immunol; 2000 May; 12(5):701-9. PubMed ID: 10784616
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
[TBL] [Abstract][Full Text] [Related]
13. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice.
Perry LL; Feilzer K; Portis JL; Caldwell HD
J Immunol; 1998 Mar; 160(6):2905-14. PubMed ID: 9510194
[TBL] [Abstract][Full Text] [Related]
14. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells.
Tanaka Y; Mine S; Hanagiri T; Hiraga T; Morimoto I; Figdor CG; van Kooyk Y; Ozawa H; Nakamura T; Yasumoto K; Eto S
Cancer Res; 1998 Sep; 58(18):4138-45. PubMed ID: 9751626
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
16. A role of interferon-gamma (IFN-gamma) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-gamma-deficient mice.
Nakajima C; Uekusa Y; Iwasaki M; Yamaguchi N; Mukai T; Gao P; Tomura M; Ono S; Tsujimura T; Fujiwara H; Hamaoka T
Cancer Res; 2001 Apr; 61(8):3399-405. PubMed ID: 11309299
[TBL] [Abstract][Full Text] [Related]
17. Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production.
Utsumi K; Takai Y; Tada T; Ohzeki S; Fujiwara H; Hamaoka T
J Immunol; 1990 Jul; 145(1):397-403. PubMed ID: 1972720
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
[TBL] [Abstract][Full Text] [Related]
19. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
